Role of Surgery in the Management for Gastric Cancer with Synchronous Distant Metastases

Overview

Journal Indian J Surg Oncol

Specialty Oncology

Date 2016 Apr 12

PMID 27065679

Citations 7

Authors

Masahide Ikeguchi

Kozo Miyatani

Seigo Takaya

Tomoyuki Matsunaga

Youji Fukumoto

Tomohiro Osaki

Hiroaki Saito

Toshiro Wakatsuki

Affiliations

Soon will be listed here.

Abstract

Optimal treatment of patients with gastric cancer with synchronous distant metastases is palliative chemotherapy. However, occasionally gastrectomy should be selected due to control bleeding from tumors, perforation, or obstruction. The aim of this study is to evaluate the survival benefits of non-curative gastrectomy for patients with synchronous distant metastasis. Total 78 gastric cancer patients with synchronous distant metastasis treated in our hospital between 2003 and 2012 were enrolled in this study. Of these, 74 patients (95 %) received S1 based chemotherapy. During the treatment, 37 patients (47.4 %) underwent palliative gastrectomy because of bleeding from tumors (n = 15), tumor perforation (n = 6), and obstruction (n = 16). Survival benefits were compared in resected and non-resected patients, retrospectively. The two groups were clinicopathologically similar. Palliative gastrectomy was performed safely (morbidity: 10.8 % and mortality: 0) in resection group. However, resection showed survival benefits only in 13 patients (16.7 %) with single metastasis and without peritoneal metastasis. Their 2-year survival rate was 40 % and their median survival was 19 months. Non-curative gastrectomy with precise surgical techniques followed careful postoperative nutrition management may improve survival only for patients with a single metastatic site, except for peritoneal dissemination.

Citing Articles

Are Palliative Interventions Worth the Risk in Advanced Gastric Cancer? A Systematic Review.

Gingrich A, Flojo R, Walsh A, Olson J, Hanson D, Bateni S J Clin Med. 2024; 13(19).

PMID: 39407868 PMC: 11478195. DOI: 10.3390/jcm13195809.

LINC00562 drives gastric cancer development by regulating miR-4636-AP1S3 axis.

Xu L, Liu D, Wang X Korean J Physiol Pharmacol. 2023; 27(3):197-208.

PMID: 37078294 PMC: 10123001. DOI: 10.4196/kjpp.2023.27.3.197.

Peri-operative Outcomes and Survival Following Palliative Gastrectomy for Gastric Cancer: a Systematic Review and Meta-analysis.

Cowling J, Gorman B, Riaz A, Bundred J, Kamarajah S, Evans R J Gastrointest Cancer. 2020; 52(1):41-56.

PMID: 32959118 PMC: 7900337. DOI: 10.1007/s12029-020-00519-4.

Gastrectomy for Metastatic Gastric Cancer: a 15-year Experience from a Developing Country.

Sahakyan M, Gabrielyan A, Aghayan D, Yesayan S, Petrosyan H, Chobanyan A Indian J Surg Oncol. 2019; 10(3):527-534.

PMID: 31496605 PMC: 6708031. DOI: 10.1007/s13193-019-00943-4.

Outcomes of gastrectomy following upfront chemotherapy in advanced gastric cancer patients with a single noncurable factor: a cohort study.

Li W, Jiang H, Yu Y, Wang Y, Wang Z, Cui Y Cancer Manag Res. 2019; 11:2007-2013.

PMID: 30881125 PMC: 6407509. DOI: 10.2147/CMAR.S192570.

References

Tsuchida K, Yoshikawa T, Tsuburaya A, Cho H, Kobayashi O . Indications for staging laparoscopy in clinical T4M0 gastric cancer. World J Surg. 2011; 35(12):2703-9. DOI: 10.1007/s00268-011-1290-5. View

Samarasam I, Chandran B, Sitaram V, Perakath B, Nair A, Mathew G . Palliative gastrectomy in advanced gastric cancer: is it worthwhile?. ANZ J Surg. 2006; 76(1-2):60-3. DOI: 10.1111/j.1445-2197.2006.03649.x. View

Saidi R, Remine S, Dudrick P, Hanna N . Is there a role for palliative gastrectomy in patients with stage IV gastric cancer?. World J Surg. 2005; 30(1):21-7. DOI: 10.1007/s00268-005-0129-3. View

Lin S, Tong H, You T, Yu Y, Wu W, Chen C . Palliative gastrectomy and chemotherapy for stage IV gastric cancer. J Cancer Res Clin Oncol. 2007; 134(2):187-92. DOI: 10.1007/s00432-007-0268-z. View

Ouchi K, Sugawara T, Ono H, Fujiya T, Kamiyama Y, Kakugawa Y . Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J Surg Oncol. 1998; 69(1):41-4. DOI: 10.1002/(sici)1096-9098(199809)69:1<41::aid-jso8>3.0.co;2-k. View

Tokunaga M, Terashima M, Tanizawa Y, Bando E, Kawamura T, Yasui H . Survival benefit of palliative gastrectomy in gastric cancer patients with peritoneal metastasis. World J Surg. 2012; 36(11):2637-43. DOI: 10.1007/s00268-012-1721-y. View

Onate-Ocana L, Mendez-Cruz G, Hernandez-Ramos R, Becker M, Carrillo J, Herrera-Goepfert R . Experience of surgical morbidity after palliative surgery in patients with gastric carcinoma. Gastric Cancer. 2007; 10(4):215-20. DOI: 10.1007/s10120-007-0437-4. View

Hartgrink H, Putter H, Kranenbarg E, Bonenkamp J, van de Velde C . Value of palliative resection in gastric cancer. Br J Surg. 2002; 89(11):1438-43. DOI: 10.1046/j.1365-2168.2002.02220.x. View

Lim S, Muhs B, Marcus S, Newman E, Berman R, Hiotis S . Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?. J Surg Oncol. 2007; 95(2):118-22. DOI: 10.1002/jso.20328. View

10.

Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M . S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008; 9(3):215-21. DOI: 10.1016/S1470-2045(08)70035-4. View

11.

Tokunaga M, Ohyama S, Hiki N, Fukunaga T, Aikou S, Yamaguchi T . Can superextended lymph node dissection be justified for gastric cancer with pathologically positive para-aortic lymph nodes?. Ann Surg Oncol. 2010; 17(8):2031-6. DOI: 10.1245/s10434-010-0969-4. View

12.

Monson J, Donohue J, MCILRATH D, Farnell M, Ilstrup D . Total gastrectomy for advanced cancer. A worthwhile palliative procedure. Cancer. 1991; 68(9):1863-8. DOI: 10.1002/1097-0142(19911101)68:9<1863::aid-cncr2820680902>3.0.co;2-1. View

13.

. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011; 14(2):101-12. DOI: 10.1007/s10120-011-0041-5. View

14.

Yagi Y, Seshimo A, Kameoka S . Prognostic factors in stage IV gastric cancer: univariate and multivariate analyses. Gastric Cancer. 2002; 3(2):71-80. DOI: 10.1007/pl00011699. View

15.

Sugarbaker P, Yonemura Y . Palliation with a glimmer of hope: management of resectable gastric cancer with peritoneal carcinomatosis. Hepatogastroenterology. 2001; 48(41):1238-47. View

16.

Keranen I, Kylanpaa L, Udd M, Louhimo J, Lepisto A, Halttunen J . Gastric outlet obstruction in gastric cancer: a comparison of three palliative methods. J Surg Oncol. 2014; 108(8):537-41. DOI: 10.1002/jso.23442. View

17.

Nashimoto A, Akazawa K, Isobe Y, Miyashiro I, Katai H, Kodera Y . Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer. 2012; 16(1):1-27. PMC: 3549249. DOI: 10.1007/s10120-012-0163-4. View

18.

Chen S, Li Y, Feng X, Zhou Z, Yuan X, Chen Y . Significance of palliative gastrectomy for late-stage gastric cancer patients. J Surg Oncol. 2012; 106(7):862-71. DOI: 10.1002/jso.23158. View

19.

Buccheri G, Ferrigno D, Tamburini M . Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer. 1996; 32A(7):1135-41. DOI: 10.1016/0959-8049(95)00664-8. View

20.

Sakamoto Y, Ohyama S, Yamamoto J, Yamada K, Seki M, Ohta K . Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery. 2003; 133(5):507-11. DOI: 10.1067/msy.2003.147. View